Phospho-GSK-3β (Ser9) AntibodyProduct information
Product Pathways - PI3K / Akt Signaling
Phospho-GSK-3β (Ser9) Antibody #9336
|9336L||300 µl (30 western blots)||---||In Stock||---|
|9336S||100 µl (10 western blots)||---||In Stock||---|
|9336||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||46||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Species predicted to react based on 100% sequence homology: Zebrafish, Bovine.
Specificity / Sensitivity
Phospho-GSK-3beta (Ser9) Antibody detects endogenous levels of GSK-3β only when phosphorylated at serine 9. The antibody may cross-react weakly with the phosphorylated form of GSK-3α due to high sequence homology.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to the sequence of human GSK-3β. Antibodies are purified by protein A and peptide affinity chromatography.
Glycogen synthase kinase-3 (GSK-3) was initially identified as an enzyme that regulates glycogen synthesis in response to insulin (1). GSK-3 is a ubiquitously expressed serine/threonine protein kinase that phosphorylates and inactivates glycogen synthase. GSK-3 is a critical downstream element of the PI3K/Akt cell survival pathway whose activity can be inhibited by Akt-mediated phosphorylation at Ser21 of GSK-3α and Ser9 of GSK-3β (2,3). GSK-3 has been implicated in the regulation of cell fate in Dictyostelium and is a component of the Wnt signaling pathway required for Drosophila, Xenopus, and mammalian development (4). GSK-3 has been shown to regulate cyclin D1 proteolysis and subcellular localization (5).
- Crowder, R.J. and Freeman, R.S. (2000) J. Biol. Chem. 275, 34266-34271. Applications: Western Blotting.
- Fasshauer, M. et al. (2000) J. Biol. Chem. 275, 25494-25501. Applications: Western Blotting.
- Ohteki, T. et al. (2000) J. Exp. Med. 192, 991-104. Applications: Western Blotting.
- Okano, J. et al. (2000) J. Biol. Chem. 275, 30934-30942. Applications: Western Blotting.
- Nakamura, N. et al. (2000) Mol. Cell. Biol. 20, 8969-8982. Applications: Western Blotting.
- Morfini, G. et al. (2002) EMBO 21 (3), 281-293. Applications: IC-IF.
- Vitari, A.C. et al. (2004) Biochem J 378, 257-68. Applications: Western Blotting.
- Hirai, S. et al. (2006) J Neurosci 26, 11992-2002. Applications: Western Blotting.
- Fujita, H. et al. (2005) Biochem Pharmacol 69, 1773-84. Applications: Western Blotting.
- Guertin, D.A. et al. (2009) Cancer Cell 15, 148-59. Applications: Western Blotting.
- Kubota, H. et al. (2012) Mol Cell 46, 820-32. Applications: Western Blotting.
- Jinesh, G.G. et al. (2012) Cell Death Differ , . Applications: Western Blotting.
- Green, H.F. and Nolan, Y.M. (2012) Transl Psychiatry 2, e194. Applications: Western Blotting.
- Green, H.F. and Nolan, Y.M. (2012) Neurochem Int 61, 666-71. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 9315 GSK-3β (27C10) Rabbit mAb
- 12456 GSK-3β (D5C5Z) XP® Rabbit mAb
- 9916 Phospho-Akt Pathway Antibody Sampler Kit
- 9316 Phospho-GSK-3α (Ser21) (36E9) Rabbit mAb
- 9323 Phospho-GSK-3β (Ser9) (5B3) Rabbit mAb
- 5558 Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.